GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LigaChem Biosciences Inc (XKRX:141080) » Definitions » Shiller PE Ratio

LigaChem Biosciences (XKRX:141080) Shiller PE Ratio : (As of Jun. 01, 2024)


View and export this data going back to 2013. Start your Free Trial

What is LigaChem Biosciences Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


LigaChem Biosciences Shiller PE Ratio Historical Data

The historical data trend for LigaChem Biosciences's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LigaChem Biosciences Shiller PE Ratio Chart

LigaChem Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

LigaChem Biosciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of LigaChem Biosciences's Shiller PE Ratio

For the Biotechnology subindustry, LigaChem Biosciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LigaChem Biosciences's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LigaChem Biosciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where LigaChem Biosciences's Shiller PE Ratio falls into.



LigaChem Biosciences Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

LigaChem Biosciences's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, LigaChem Biosciences's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=328/118.8477*118.8477
=328.000

Current CPI (Mar. 2024) = 118.8477.

LigaChem Biosciences Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -124.000 99.353 -148.331
201409 -148.500 99.608 -177.183
201412 -219.000 99.098 -262.646
201503 -149.500 99.720 -178.176
201506 -144.000 100.050 -171.055
201509 -126.500 100.110 -150.177
201512 -113.500 100.220 -134.596
201603 -96.500 100.560 -114.049
201606 -147.500 100.790 -173.926
201609 -121.000 101.460 -141.736
201612 -427.500 101.560 -500.270
201703 -160.000 102.850 -184.887
201706 -122.500 102.610 -141.885
201709 -97.500 103.490 -111.969
201712 -270.000 102.990 -311.573
201803 -115.000 104.100 -131.292
201806 -50.000 104.130 -57.067
201809 -313.500 105.650 -352.662
201812 -743.500 104.350 -846.797
201903 4.500 104.490 5.118
201906 -102.500 104.880 -116.151
201909 770.500 105.200 870.458
201912 -107.000 105.120 -120.973
202003 -69.500 105.540 -78.263
202006 276.000 104.870 312.787
202009 -227.000 106.200 -254.034
202012 -104.312 105.765 -117.215
202103 -558.000 107.357 -617.723
202106 -649.000 107.579 -716.984
202109 -363.000 108.759 -396.672
202112 600.000 109.676 650.173
202203 -351.000 111.806 -373.107
202206 -322.000 114.083 -335.449
202209 -135.000 114.831 -139.722
202212 -802.000 115.200 -827.393
202303 -625.000 116.550 -637.324
202306 -760.000 117.140 -771.080
202309 -746.000 119.111 -744.350
202312 -416.000 118.848 -416.000
202403 328.000 118.848 328.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


LigaChem Biosciences  (XKRX:141080) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


LigaChem Biosciences Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of LigaChem Biosciences's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


LigaChem Biosciences (XKRX:141080) Business Description

Traded in Other Exchanges
N/A
Address
8-26 Munpyeongseo-ro, Daedeok-gu, Daejeon, KOR, 34302
LegoChem Biosciences Inc develops new drugs through research. The Company provides business research services, manufacturing and sale of compounds, and drug evaluation.

LigaChem Biosciences (XKRX:141080) Headlines

No Headlines